Calithera Biosciences (CALA) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts CALA Hot Sheet
Join SI Premium – FREE
Calithera Biosciences (NASDAQ: CALA) reported Q4 EPS of ($0.44), $0.12 better than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Calithera Biosciences (CALA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- GitLab updates consumption revenue metric, CRR surpasses $20M
- UBS Reiterates Neutral Rating on Carter's (CRI)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
